Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies
Introduction Therapeutic options for type 2 diabetes mellitus (T2DM) have expanded over the last decade with the emergence of cardioprotective novel agents, but without such data for older drugs, leaving a critical gap in our understanding of the relative effects of T2DM agents on cardiovascular ris...
Saved in:
Main Authors: | Rohan Khera, Yuan Lu, Harlan M Krumholz, Martijn J Schuemie, Ruijun Chen, George Hripcsak, Marc A Suchard, Patrick B Ryan, Anna Ostropolets |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/6/e057977.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of aortic aneurysm or dissection following use of fluoroquinolones: a retrospective multinational network cohort studyResearch in context
by: Jack L. Janetzki, et al.
Published: (2025-03-01) -
Adropin as an indicator of T2DM and its complications
by: Hu Zhang, et al.
Published: (2022-11-01) -
African Myths & Legends /
by: Ardagh, Philip
Published: (2002) -
One Map, Multiple Legends
by: Noa Roei
Published: (2021-02-01) -
Study of the ψ(1S,2S) and ηc(1S,2S) Weak Decays into DM
by: Junfeng Sun, et al.
Published: (2016-01-01)